Overview
Portfolio
More
Nbvc
China Lake, United States
Portfolio
13+
Employees
1000+
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaUnited States
Fund details
Funds
华桐恒德基金
Vintage 2016
华桐恒泰基金
Vintage 2017
华桐恒越基金
Vintage 2018
华桐恒鑫基金
Vintage 2020
Sources
Nbvc
Portfolio
13+
Employees
1000+
Founded
N/A
AUM
N/A
Funds
华桐恒德基金 · Vintage 2016
华桐恒泰基金 · Vintage 2017
华桐恒越基金 · Vintage 2018
华桐恒鑫基金 · Vintage 2020
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaUnited States
Sources
Showing 10 of 10 matched portfolio companies
AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.
Green Li-ion develops a modular hardware solution that utilizes GREEN HYDROREJUVENATION™ technology to convert spent lithium-ion batteries into precursor cathode active material, graphite, and technical-grade lithium carbonate. This process addresses the environmental impact of electronic waste by efficiently reclaiming valuable battery materials for reuse in manufacturing.
Funding: $35.5M
Rough estimate of the amount of funding raised
Funding: $35.5M
Rough estimate of the amount of funding raised
Guangdong Shi Robot provides a cold chain cloud factory platform that utilizes artificial intelligence for supply chain management. The platform enhances temperature-controlled logistics efficiency, ensuring the safe transport of perishable goods while minimizing waste and operational costs.
The startup develops targeted therapies for cancer treatment through drug discovery focused on tumor immunology. By enhancing the immune response against tumors, the company aims to improve the quality of life for cancer patients.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
This startup offers an online platform that empowers women and LGBTQ artists to launch and manage NFT initiatives, utilizing decentralized finance tools to enhance visibility and access to resources. By fostering a community-driven ecosystem, the platform addresses the lack of equitable opportunities in the crypto space for underrepresented creators.
Funding: $4.5M
Rough estimate of the amount of funding raised
Funding: $4.5M
Rough estimate of the amount of funding raised
Zyheal provides a cloud‑based health management platform that consolidates data from wearables, electronic health records, and manual inputs into a single dashboard. The system applies analytics to deliver personalized lifestyle and treatment recommendations, medication reminders, and progress visualizations, while enabling secure data sharing with clinicians for remote monitoring.
Shanghai-based Fintech company FuShu specializes in providing data-driven financial solutions that enhance transaction transparency and security for businesses. By utilizing advanced analytics and blockchain technology, FuShu addresses the challenges of fraud and inefficiency in financial operations.
MAYCUR.COM offers cloud-based financial products that utilize advanced data analytics and machine learning to enhance financial decision-making for businesses. The platform addresses inefficiencies in financial management by providing real-time insights and automated reporting, enabling companies to optimize their financial operations.
Moredian provides recognition technology that utilizes artificial intelligence to enhance accuracy in identifying and classifying objects across various industry applications. This technology addresses the challenges of manual recognition processes, improving efficiency and reducing errors in data handling.
The startup develops drugs that enhance pyroptosis, a form of programmed cell death, to trigger robust immune responses against tumors. This approach targets inflammation and tumor eradication, providing a novel therapeutic strategy for difficult-to-treat cancers.
Showing 3 of 3 unmatched portfolio companies